Who We Are
NeuroTrauma Sciences (NTS) is a biopharmaceutical company focused on developing neuroprotective and neurorestorative agents to treat brain injury including stroke, concussion, and the complications of traumatic brain injury (TBI).
What We Do
When someone suffers a serious brain injury there are currently no drugs available to alleviate the cognitive, functional, and neurobehavioral effects.
NTS is developing a portfolio of products designed to address these life impairing damages.
David Poulsen, Ph.D.
Principal Scientific Advisor
Todd Verdoorn, PhD.
NeuroTrauma Sciences LLC is a funded, privately held company.
Additional information on our investors may be made available upon request.